Publications
5803 Results
- Journal / Conference
- Lancet 374(9707):2055-2063
- Year
- 2009
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8814
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node positive breast cancer: a phase 3 open-label, randomised controlled trial [PMID20004966; PMC3140679]
- Journal / Conference
- Urologic Oncology 27(2):155-159
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8507
Failure to achieve a complete response to induction BCG therapy is associated with increased risk of progression and death in patients with high risk non-muscle invasive bladder cancer [PMC2695968; PMID18367117]
- Journal / Conference
- Blood 113(4):866-874
- Year
- 2009
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8600, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500
Very late antigen-4 (VLA-4) function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia [PMC2630271; PMID18927435]
- Journal / Conference
- Journal of Thoracic Oncology, 4(1):87-92
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0339
Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Onclogy Group study (S0339) [PMID19096312; PMC3024911]
- Journal / Conference
- Archives of Otolaryngology Head and Neck Surgery 135(9):869-874
- Year
- 2009
- Research Committee(s)
- Head and Neck
- Study Number(s)
- S0011
A phase II trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx: report of the Southwest Oncology Group [PMID19770418; PMC3098124]
- Journal / Conference
- Gynecologic Oncology 112(3):444-449
- Year
- 2009
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S0009
Phase II evaluation of neoadjuvant chemotherapy and interval debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group study S0009 [PMID19138791]
- Journal / Conference
- Investigational New Drugs 27(5):469-475
- Year
- 2009
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0336
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336) [PMID18941712; PMC3024913]
- Journal / Conference
- Journal of Clinical Oncology 27(21):3510-3517
- Year
- 2009
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0204
Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation thalidomide-prednisone maintenance for untreated multiple myeloma: a Southwest Oncology Group Trial (S0204) [PMID19546405; PMC2717757]
- Journal / Conference
- Blood 113(4)793-796
- Year
- 2009
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9003
Long term survival in Waldenstrom macroglobulinemia - 10 year follow-up of Southwest Oncology Group (SWOG) directed intergroup trial S9003 [PMID18931340; PMC2630265]
- Journal / Conference
- Journal of the National Cancer Institute 101(14):984-992
- Year
- 2009
- Research Committee(s)
- Breast, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, and Lymphoma
- Study Number(s)
- SWOG-7436, SWOG-7524, SWOG-7713/14, SWOG-7823/24/25/26, SWOG-7827, SWOG-7924, SWOG-7925, SWOG-8124/25/26, SWOG-8232, SWOG-8241, SWOG-8313 (EST 5186), SWOG-8412, SWOG-8494 (INT-0036), SWOG-8501 (INT-0051), SWOG-8516 (INT-0067), SWOG-8591(NCI Intergroup #0035), SWOG-8600, SWOG-8738, SWOG-8812, SWOG-8994 (EST-C-0690) (INT-0086), SWOG-8997 (EST-3887) (ECOG-3887), SWOG-9031, SWOG-9308, SWOG-9509